Back
Citizens Backs CRISPR Despite $24M Casgevy Sales Miss
Back
Stock News
Themes
Citizens Backs CRISPR Despite $24M Casgevy Sales Miss
AI Medical
Citizens Backs CRISPR Despite $24M Casgevy Sales Miss
Edgen Stock
·
Dec 18 2025, 03:45
Share to
Share to
Copy link
source:
[1] Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown
Recommend
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17
US-China AI Rivalry Enters New Phase Focused on Compute Power and Cybersecurity
Nov 28 2025, 10:17
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17